pathway are the enzyme choline acetyltransferase (ChAT) that synthesises acetylcholine (ACh), the enzyme acetylcholinesterase (AChE) that hydrolyses ACh, and the acetylcholine receptors. ACh signals through two types of unrelated membrane receptors referred to as nicotinic (nAChR) and muscarinic (mAChR) acetylcholine receptors (see, e.g., Hosey, 1992) . Muscarinic receptors mediate several actions of ACh in the central and peripheral nervous systems and in cardiac tissue. Muscarinic receptors are pharmacologically classified into three types designated as M1-M3, although five different genes (m1-m5) have been identified in rodents (Mei et al., 1989; Hulme et al., 1990) . The M1, M2, and M3 types correspond to the m1, m2, and m3 molecular isoforms, respectively. In general, it is accepted that m2-and m4-encoded gene products are coupled to inhibition of adenylate cyclase, whereas m1-, m3-, and m5-encoded gene products are acting via stimulation of inositol triphosphate and diacylglycerol production (Hulme et al., 1990) . In the adult heart, ACh released from parasympathetic nerve terminals acts on mAChR to decrease both the rate and the force of contraction by mediating the inhibition of adenylate cyclase (Tang and Gilman, 1992) and the stimulation of inositol triphosphate and diacylglycerol production (Barnett et al., 1990; Masters et al., 1985) .
ChAT is the enzyme that catalyses the formation of the ACh. ChAT localisation is always restricted to neural tissue and, hence, is a more reliable marker to assess cholinergic innervation than is AChE (Eckenstein and Sofroniew, 1983; Appleyard, 1992) . ChAT activity has been demonstrated in the rat heart from 19 embryonic days (ED) onward (Marvin et al., 1980) , but no information is available concerning its cardiac localisation.
AChE activity has been detected in early embryonic rat (Lamers et al., 1987; Nakamura et al., 1994) and chicken (Lamers et al., 1990) hearts, where it is expressed in the myocardial layer of the outflow tract and in the ventricular trabeculations. Its expression declines in the fetal period and disappears shortly after birth. Because these parts of the heart are characterised by a long duration of the contraction (De Jong et al., 1992; Moorman and Lamers, 1994) , an AChdependent calcium mobilisation has been suggested to play an important role in those areas expressing high AChE activity (Lamers et al., 1990) . In vitro experiments in embryonic chicken cardiac cells showed that ACh stimulation of mAChRs results in intracellular accumulation of inositol triphosphate (Oettling et al., 1989 (Oettling et al., , 1992 Lohmann et al., 1991) . These data suggest that these mAChRs belong to the m1, m3, or m5 subtype. Inositol triphosphate accumulation results in an increased intracellular calcium content that triggers contraction.
In this study we wished to test whether such a mechanism is effectively present in the embryonic rat heart. For that purpose, we studied the mRNA expression patterns of AChE, ChAT, and the five mAChRs isoforms described so far.
MATERIALS AND METHODS Embryos
Wistar rat embryos were obtained from timedpregnant rats (12-20 embryonic days; ED). Neonatal hearts (3, 8, and 10 days old) and adult hearts (3 months old) and adult spinal cord were also processed. Samples were fixed for 4 hr in 4% freshly prepared formaldehyde in phosphate-buffered saline (PBS) at room temperature (in situ hybridisation) or overnight in methanol:acetone:water (2:2:1; immunohistochemistry). The embryos and tissues were dehydrated in a graded series of ethanol and embedded in paraplast. Serial sections were cut at 7 µm thickness and mounted on RNAse-free 3-aminopropyltriethoxysilane (AAS)coated slides (in situ hybridisation) or on polylysinecoated slides (immunohistochemistry).
In Situ Hybridisation
Complementary RNA probes of rat ChAT mRNA (Brice et al., 1989) ; human AChE mRNA (Soreq et al., 1990) ; rat b-myosin heavy chain (b-MHC) mRNA; sarcoplasmic reticulum calcium ATPase (SERCA2) (Moorman et al., 1995) ; glutamine synthetase (GS) mRNA (van der Zande, 1989); and human m1, m2, m3, m4, and m5 mAChRs (Peralta et al., 1987) mRNAs were radiolabelled with 35 S-UTP by in vitro transcription according to standard protocols (Melton et al., 1984) . ChAT cDNA [EcoRI-NcoI; nucleotides (nt) 1-1870] was subcloned into pBluescript (Stratagene). AChE cDNA was linearised with BstXI (nt 1484-2227), BstEII (nt 822-2227), or Asp718 (full length) to assess the specificity of the probe. Linearisation of AChE cDNA with BstXI gave the lowest background signal and therefore was eventually used. Human m1 (StuI-SacI; nt 1259-1410), m2 (BamHI-RsaI; nt 995-1204), m3 (AvaI-AvaI; nt 1586 -1975 , m4 (HindIII-PstI; nt 867-1114), and m5 (AccI-TaqI; nt 1038-1308) fragments were subcloned into pBluescript (Stratagene) to obtain probes that were specific for each subtype.
The hybridisation conditions were as detailed elsewhere (Moorman et al., 1995) . Briefly, the sections were deparaffinised, rinsed in absolute ethanol, and dried in an air stream. Pretreatment of the sections was as follows: 20 min 0.2 N HCl, 5 min bidistilled water, 20 min 23 SSC (70°C), 5 min bidistilled water, 2-20 min digestion in 0.1% pepsin dissolved in 0.01 N HCl, 30 sec in 0.2% glycine/PBS, twice for 30 sec each in PBS, 20 min of postfixation in 4% freshly prepared formaldehyde, 5 min in bidistilled water, 5 min in 10 mM EDTA, 5 min in 10 mM dithiothreitol (DTT), and finally drying in an air stream. The prehybridisation mixture contained 50% formamide, 10% dextransulphate, 23 SSC, 23 Denhardt's solution, 0.1% Triton X-100, 10 mM DTT, and 200 ng/µl heat-denatured herring sperm DNA. The sections were hybridised overnight at 52°C and washed as follows: a rinse in 13 SSC; 30 min at 52°C in 50% formamide dissolved in 13 SSC; 10 min in 13 SSC; 30 min in RNAse A (10 µg/ml); 10 min in 13 SSC; 10 min in 0.13 SSC; and dehydration in 50%, 70%, and 90% ethanol containing 0.3 M ammonium acetate. The sections were dried and immersed in nuclear autoradiographic emulsion (Ilford). The exposure time ranged from 10 to 24 days and the development time from 4 to 8 minutes as indicated. Photographs were taken with a Zeiss Axiophot microscope, using Agfa 25ASA films.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Embryos ranging from 13ED to 20ED were used to isolate total RNA according to Chomszynski and Sacchi (1987) . Embryos were excised from the uterus in icecold sterile PBS, and the hearts were removed and the atria and ventricles were dissected separately. Total RNA from embryonic ventricles at different stages, 16ED rat spinal cord (16SP), adult spinal cord (SP), adult ventricles (AV), and adult liver (L), were isolated. 13ED and 14ED embryos from two different litters were pooled. RNA samples were stored (220°C) in TE containing 0.01% sodium dodecyl sulfate (SDS). The single-step RT-PCR reaction according to Aatsinki et al. (1994) was performed in 50 µl total volume containing 3 µg total RNA, 100 pmol of each oligonucleotide, 100 µM dNTPs, 100 mM Tris HCl buffer (pH 8.2), 0.01% bovine serum albumin (BSA), 1.5 mM MgCl 2 , 10U AMV-RT (Promega), and 2.5 U Taq polymerase (Eurogentec, Berse, Belgium). Briefly, an initial annealing step (15 min, 65°C) was performed. Subsequently, the reaction mixture was incubated at 42°C (1 hr, RT step) and heated for 5 min at 95°C (96°C for AChE oligonucleotides; RT denaturation step). Thirty-five PCR cycles were performed as follows: 1 min at 95°C (denaturation step), 2 min at 52°C (60°C for AChE oligonucleotides; annealing step), 10 min at 72°C (elongation step), with a final elongation step of 5 min at 72°C. Specific 30-mer oligonucleotides as designed by Soreq et al. (1994) were used to distinguish between AChE and butyrylcholinesterase mRNA. These sequences were adapted to the rat AChE cDNA (Brice et al., 1989) . Specific oligonucleotides complementary to AChE and GS mRNAs, respectively, were designed to distinguish amplified mRNA product from amplified genomic (DNA) product (an intron was always present between the upstream and downstream oligonucleotides; see Table 1 ). Amplifica-tion of GS mRNA resulted in a fragment 555 nt in length, whereas the corresponding genomic fragment (gDNA) was 4 kilobases (kb) in length. Amplification of AChE mRNA resulted in a fragment of 786 nt length, whereas its corresponding genomic fragment was 1186 nt. RT-PCR products were loaded and run on a 1% agarose gel and transferred to nylon membranes (Hybond N; Amersham, Amersham, U.K.). Southern blots were performed according to Sambrook et al. (1989) and hybridised to full-length AChE cDNA or an 800 bp EcoRI fragment of the rat GS cDNA (van der Zande, 1989). 32 P labelling of the cDNAs was by the randomprimed method. Unincorporated dNTPs were removed on Sephadex G-50 columns. Probes were quantified in a liquid scintillation counter (1900CA Tri-Carb; Packard) and hybridised overnight at 52°C. Membranes were washed in 40 mM sodium phosphate 1% SDS buffer (52°C, 2 3 15 min; RT, 1 3 30 min). A final wash with buffer only was performed. The membranes were then exposed in a phosphorimage analyser (Molecular Dynamics) for 2-3 hr and analysed.
Immunohistochemistry
Specific primary monoclonal antibodies against rat 68 kD neurofilament protein (Dako Inc.), Leu-7 (Becton-Dickinson Co.), a-smooth muscle actin (Sigma), and b-myosin heavy chain (Wessels et al., 1991) were used to visualise the neural tissue and the myocardium. After deparaffination and hydration, the sections were washed in PBS and treated with hydrogen peroxide (3% in PBS, 30 min) to reduce endogenous peroxidase activity. Subsequently, an incubation in TENG-T (10 mM Tris, 5 mM EDTA, 150 mM NaCl, 0.25% gelatin, 0.05% Tween-20, pH 8.0; 30 min) was performed to avoid nonspecific binding. After this pretreatment, the sections were incubated overnight with the specific primary antibody. Binding of the first antibody was detected using a rabbit antimouse immunoglobulin, followed by a goat antirabbit immunoglobulin and finally a rabbit peroxidase antiperoxidase (PAP) complex. Each incubation lasted 2 hr and was followed by three washes in PBS (5 min each). All sera were diluted in PBS. The visualisation of the PAP complex was performed by incubation with 0.5 mg/ml 3,38-diaminobenzidine and 0.02% hydrogen peroxide in 30 mM imidazole, 1 mM EDTA (pH 7.0) buffer. Sections were dehydrated and mounted in Entellan (Merck).
RESULTS

In Situ Hybridization
In the present study, adult brain and spinal cord and embryonic spinal cord were used to assess the specificity of AChE, ChAT, and mAChR mRNA localisation. GS (neural tissue and myocardium), SERCA2, and b-MHC mRNAs were used as internal controls of embryonic and adult hearts. The expression pattern of the respective mRNAs is first described for control tissues and subsequently for the heart.
Adult neural tissue
The specificity of the ChAT, AChE, and mAChRs mRNAs was evaluated using adult rat spinal cord and brain. Figure 1A ,B illustrates the expression patterns of AChE and ChAT mRNAs, respectively. These mRNAs were found to be specifically localised in the perinuclear area of the motor neurons of the spinal cord (see, e.g., high magnification of ChAT mRNA in Fig. 1C ). These findings are in accordance with previously published data (Oh et al., 1992; Vilaro et al., 1992; Lauterborn et al., 1993; Landwehrmeyer et al., 1993; Hoover et al., 1994) , demonstrating that we could reliably visualise these rare mRNAs.
Neonatal and adult heart
The expression pattern of the different mRNAs studied in neonatal and adult specimens did not show significant differences, so no further distinction is made in the description. The expression of ChAT ( Fig. 2A,B ,E) and AChE (Fig. 2D ) mRNAs was found to be restricted to the cardiac ganglia. These ganglia were found on the dorsal wall of the atria and around the pulmonary veins, reaching laterally as far as the caval veins. Some neurons were found in the atrioventricular groove ( Fig.  2D-F) . The mRNAs of the muscarinic receptor types m1, m2, and m4, but not m3 and m5, were localised in the same structures as AChE and ChAT mRNAs (Fig.  3) . None of the mRNAs studied was observed at detectable levels within the working myocardium or in the conduction system (i.e., sinoatrial and atrioventricular nodes and ventricular conduction system).
Embryonic and fetal neural tissue
ChAT and AChE mRNAs were observed in the ventral horns of the spinal cord from 13ED onward. Only muscarinic receptors type m1, m2, and m3 (but not m4 or m5) were very weakly expressed in the spinal cord during early embryogenesis (13ED-15ED; data not shown). None of the mRNAs studied was expressed at detectable levels in the peripheral vagal nerves or in the intracardiac nerves during the fetal period.
Embryonic and fetal heart
The myocardium of the outflow tract (OFT) and the ventricular trabeculations do not contain detectable levels of AChE, ChAT, or mAChR mRNAs during any stage of development ( Fig. 4B-D) . The first cells containing AChE and ChAT mRNAs were observed in the dorsal wall of the atrium at 15ED (Fig. 5B ), but those cells were not myocardial cells, as demonstrated by comparison with the expression of b-MHC mRNA (Fig.  5A) . From 16ED onward, AChE and ChAT mRNAs showed a well-defined pattern, which, based on immunohistochemistry with monoclonal antibodies against neurofilament proteins and Leu-7 antigens, corresponded to the cardiac ganglia. The cardiac ganglia developed several branches towards the superior caval vein and the interventricular groove and around the pulmonary veins ( Fig. 5E-G) . Their final distribution pattern was achieved around 20ED (Fig. 6 ).
Muscarinic receptors (m1, m2, and m4) mRNAs could be clearly demonstrated from 18ED onward in the cardiac ganglia ( Fig. 7A-C) . The m1 and m4 subtypes were also observed in the vascular smooth muscle cells and lung buds ( Fig. 7A,C) . The m1 and m4 subtypes were slightly more abundant than the m2 subtype in the cardiac ganglia during the fetal period ( Fig. 7B ). On the other hand, no detectable level above background was observed for the m3 and m5 mAChRs. The atrial myocardium shows a just detectable hybridisation signal for the m1 and m4 mAChR mRNAs, but this was not the case for the ventricular myocardium. No differences regarding the mAChR mRNAs were found in the developing conduction system (SA and AV nodes, and ventricular conduction system) compared to the surrounding myocardium. The pattern of expression of the mAChRs during the fetal and adult periods is summarised in Table 2 .
RT-PCR
AChE is an enzyme with an extremely high turnover rate, so, potentially, only very low levels of protein, and hence mRNA, are necessary to generate detectable activity levels. To obtain more definitive data about the absence or presence of AChE mRNA during early rat heart development, we applied RT-PCR to total RNA extracts from embryonic ventricles. Embryonic ven-tricles were used to avoid possible contamination with the cardiac ganglia. Furthermore, the OFT was removed to exclude nerves in the arterial pole of the heart. In effect, we therefore determined whether or not the trabeculations contain AChE mRNA. AChE and GS primers were tested in adult rat spinal cord, adult basal nuclei, and 16ED spinal cord, total RNA generating the expected fragments.
No AChE mRNA could be detected in extracts of ventricles between 13ED and 18ED (Fig. 8A) . RT-PCR of GS mRNA, which served as a control of the RT procedure, showed that the RNA was of sufficient quality to allow the detection of low-abundance mRNAs (Fig. 8B) . Therefore, both the in situ hybridisation and the RT-PCR data show that no mRNA coding for the Fig. 3 . Neonatal heart. Expression of m1 (A), m2 (B), and m4 (C) mAChR mRNAs in transverse sections of a 10-day-old rat heart. Observe that the expression of the mAChRs is restricted to the cardiac ganglia (arrows) and is not observed in the myocardial cells. am, atrial myocardium; tr, trachea. A-C have the same magnification. Scale bar 5 100 µm.
AChE is present in the myocardium of the embryonic rat.
DISCUSSION
Within the embryonic heart, five different compartments can be distinguished according to their electrophysiological characteristics. These segments are a slow-conducting inflow tract, the fast-conducting atria, a slow-conducting atrioventricular canal, the fastconducting ventricles, and a slow-conducting outflow tract (Arguello et al., 1986; De Jong et al., 1992) . In addition, the upstream venous part of the heart is characterised by short contractions, whereas the downstream arterial part is characterised by long-lasting contractions (De Jong et al., 1992; Moorman and Lamers, 1994) . Each of these compartments therefore acquires a distinct molecular phenotype that reflects this functional heterogeneity (Moorman and Lamers, 1994) .
The characterisation of the mechanisms underlying the differences in the contraction-relaxation cycle in the arterial and venous poles of the heart is far from complete. Changes in the free intracellular calcium concentrations are an important effector regulating contraction-relaxation states within myocytes. The group of Drews (Oettling et al., 1989 (Oettling et al., , 1992 Lohmann et al., 1991) has identified the transient presence of a muscarinic, inositiol triphosphate-dependent calciummobilising pathway in isolated cardiomyocytes of embry- onic chickens. These findings appeared to provide a functional role for the AChE activity that we (Lamers et al., 1987 (Lamers et al., , 1990 and others (Coraboeuf et al., 1970; Nakamura et al., 1994) have observed in the myocardium of the ventricular trabeculations and the outflow tract of embryonic and fetal hearts of rats and chickens. The use of appropriate inhibitors excluded the possibility that a nonspecific cholinesterase or esterase activity was involved. Furthermore, Paff et al. (1966) identified a less well-defined ACh-dependent regulation of cardiac rhythmicity in early chicken embryos that was localised at the atrioventricular junction.
Unexpectedly, we have shown in the present study that neither ChAT nor AChE mRNA can be detected in the prenatal rat myocardium. A similar paradox, i.e., the presence of AChE activity and the absence of its mRNA, was recently reported for embryonic rabbit hearts by using the Northern blotting technique (Jbilo et al., 1994) . Because AChE is an enzyme with an extremely high turnover rate, potentially only very low levels of mRNA are necessary to generate AChE protein and, hence, detectable activity levels. On the other hand, our in situ hybridisation study did show that mRNAs of AChE, ChAT, and mAChRs are present from 15ED (AChE, ChAT) and 18ED (mAChRs) onward in the cardiac ganglia on the dorsal wall of the atria. This demonstrates that we were able to localise these mRNAs specifically in embryonic tissues. Furthermore, only a very low level of m1 and m4 mAChR mRNA is present in the atria of prenatal rats. None of these mRNAs could be visualised by in situ hybridisation in the ventricular trabeculations or in the outflow tract myocardium. Moreover, no AChE mRNA could be demonstrated in the ventricles by the very sensitive RT-PCR technique. On the other hand, this method revealed the presence of GS mRNA, which also could not be visualised by in situ hybridisation in these embryonic hearts.
As stated, the presence of true AChE activity in the ventricular trabeculations and the outflow tract was demonstrated by the use of specific inhibitors. Unfortu-nately, AChE protein has not yet been demonstrated in the heart. This is because the AChE activity measurement requires only a very low AChE protein concentration and because the specific monoclonal antibodies that were raised against the human (Brimijoin et al., 1983) and the chicken (Chatel et al., 1994) AChE subunits do not cross-react well with the rat protein.
Nevertheless, the paradoxical presence of AChE activity has to be reconciled with the absence of its encoding mRNA. We can hypothesise that AChE protein is derived from other sources, via diffusion or the circulation. Innervation of the heart has not yet developed at 13ED (Gomez, 1958) , when AChE activity is already demonstrable (Lamers et al., 1990) . It is well documented that AChE can be present in different molecular forms, being either soluble (globular forms) or insoluble (attached to membranes; asymmetrical forms; see, e.g., Massoulie and Bon, 1982) . Interestingly, both molecular forms of AChE are present in adult rat heart. The asymmetrical isoforms are homogeneously distributed, whereas globular isoforms are more highly expressed in the atria than in the ventricles Trans-Saltmann, 1989, 1990) . So far, no data are available about the embryonic heart in this respect.
Even if the AChE of the arterial pole of the embryonic heart was synthesised elsewhere, for it to be part of an ACh-dependent signal-transduction pathway would require the presence of specific receptors. In adult rats, muscarinic receptors are present in higher concentrations in the atria and the conduction system than in ventricles (Hancock et al., 1987) as revealed by autoradiographic studies. More recently, a comparison between radiolabeled binding assays and immunohistochemical localisation of mAChRs in the embryonic mouse pointed out that both protein and binding activity colocalised in the ventricular myocardiocytes (Lammerding-Koppel et al., 1995) . However, in situ hybridisation studies have shown that no mAChRs mRNA is observed in the ventricular myocardium and that only m2 mRNA is expressed in adult rat atria. Furthermore, no differences were seen between conduction system (nodal and ventricular) and working myocardium (Hoover et al., 1994; this study) . Within the cardiac ganglia, m2 mRNA was also found as the predominant subtype, but lower amounts of m1 and m4 were present (Hoover et al., 1994) . These data support the ACh sensitivity of the atrium but not of the more downstream myocardium. The presence of ACh binding activity in the conduction system and the absence of local mRNA concentration, as has also been discussed by other authors (Hoover et al., 1994) , is paradoxical. It implies that only a few mRNA molecules, below the delection level of in situ hybridisation, are capable of generating enough mAChRs to be visualised by means of immunohistochemistry and autoradiographic binding assays. Current studies aim to address this point.
Even though the best defined role of the AChE is to hydrolyse ACh (Small, 1989 (Small, , 1990 Appleyard, 1992) , AChE activity has been found in other locations where other components of the cholinergic signal-transduction pathway are lacking, such as migrating neural crest-derived cells (Miki and Mizoguti, 1982; Cochard and Coltey, 1983) , adult placenta, erythrocytes, platelets, and lymphocytes (see, e.g., Small, 1989 Small, , 1990 . Furthermore, AChE activity is not always colocalised with ChAT in adult brain (Levey et al., 1983) . These data suggest that AChE can play a role other than hydrolysis of ACh (see Small, 1989 Small, , 1990 . AChE sequence analysis has revealed that some domains share similarities with exopeptidases, such as the trypsinlike serine protease family. Therefore, roles as a protease (Chubb et al., 1980) , zymogen (i.e., an inactive protease precursor; Small, 1989) , and morphogenetic factor (Miki and Mizoguti, 1982; Drews and Mengis, 1990; Lammerding-Koppel et al., 1995) have been hypothesised for the AChE. Our results support the notion that AChE plays such a role during embryonic heart development. ACKNOWLEDGMENTS D.F. is the recipient of fellowship EX93-27383269 from the ''Ministerio de Educación y Ciencia'' of Spain. 
